Problems in the design of anticancer agents

M. D'Incalci, G. Balconi, M. Broggini, T. Colombo, M. Marzola, F. Morali, Y. Pang, S. Sen, L. Spinelli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Theoretically, two predominant paths for obtaining more selective anticancer agents may be envisaged. These are: (a) to make compounds which distribute only or preferentially in cancer cells; (b) to make compounds that are able selectively to kill or to differentiate cancer cells. Although in the last two decades research into new anticancer drugs has not produced satisfactory results, there is solid ground on which novel strategies can be developed, mainly based on a much greater biological knowledge of human tumours. This article does not review all the possible approaches that may be followed, but simply discusses some ideas and problems mainly taken from the current research of our laboratory.

Original languageEnglish
Pages (from-to)535-555
Number of pages21
JournalCancer Surveys
Volume8
Issue number3
Publication statusPublished - 1989

Fingerprint

Antineoplastic Agents
Neoplasms
Research
Pharmaceutical Preparations

Keywords

  • antineoplastic drugs
  • distribution
  • DNA as a target of antitumour drugs
  • human cancer cells
  • immunoconjugates
  • immunotoxins

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

D'Incalci, M., Balconi, G., Broggini, M., Colombo, T., Marzola, M., Morali, F., ... Spinelli, L. (1989). Problems in the design of anticancer agents. Cancer Surveys, 8(3), 535-555.

Problems in the design of anticancer agents. / D'Incalci, M.; Balconi, G.; Broggini, M.; Colombo, T.; Marzola, M.; Morali, F.; Pang, Y.; Sen, S.; Spinelli, L.

In: Cancer Surveys, Vol. 8, No. 3, 1989, p. 535-555.

Research output: Contribution to journalArticle

D'Incalci, M, Balconi, G, Broggini, M, Colombo, T, Marzola, M, Morali, F, Pang, Y, Sen, S & Spinelli, L 1989, 'Problems in the design of anticancer agents', Cancer Surveys, vol. 8, no. 3, pp. 535-555.
D'Incalci M, Balconi G, Broggini M, Colombo T, Marzola M, Morali F et al. Problems in the design of anticancer agents. Cancer Surveys. 1989;8(3):535-555.
D'Incalci, M. ; Balconi, G. ; Broggini, M. ; Colombo, T. ; Marzola, M. ; Morali, F. ; Pang, Y. ; Sen, S. ; Spinelli, L. / Problems in the design of anticancer agents. In: Cancer Surveys. 1989 ; Vol. 8, No. 3. pp. 535-555.
@article{eaf0e8227dfb4b61a7f7c7c2a7303832,
title = "Problems in the design of anticancer agents",
abstract = "Theoretically, two predominant paths for obtaining more selective anticancer agents may be envisaged. These are: (a) to make compounds which distribute only or preferentially in cancer cells; (b) to make compounds that are able selectively to kill or to differentiate cancer cells. Although in the last two decades research into new anticancer drugs has not produced satisfactory results, there is solid ground on which novel strategies can be developed, mainly based on a much greater biological knowledge of human tumours. This article does not review all the possible approaches that may be followed, but simply discusses some ideas and problems mainly taken from the current research of our laboratory.",
keywords = "antineoplastic drugs, distribution, DNA as a target of antitumour drugs, human cancer cells, immunoconjugates, immunotoxins",
author = "M. D'Incalci and G. Balconi and M. Broggini and T. Colombo and M. Marzola and F. Morali and Y. Pang and S. Sen and L. Spinelli",
year = "1989",
language = "English",
volume = "8",
pages = "535--555",
journal = "Cancer Surveys",
issn = "0261-2429",
publisher = "Cold Spring Harbor Laboratory Press",
number = "3",

}

TY - JOUR

T1 - Problems in the design of anticancer agents

AU - D'Incalci, M.

AU - Balconi, G.

AU - Broggini, M.

AU - Colombo, T.

AU - Marzola, M.

AU - Morali, F.

AU - Pang, Y.

AU - Sen, S.

AU - Spinelli, L.

PY - 1989

Y1 - 1989

N2 - Theoretically, two predominant paths for obtaining more selective anticancer agents may be envisaged. These are: (a) to make compounds which distribute only or preferentially in cancer cells; (b) to make compounds that are able selectively to kill or to differentiate cancer cells. Although in the last two decades research into new anticancer drugs has not produced satisfactory results, there is solid ground on which novel strategies can be developed, mainly based on a much greater biological knowledge of human tumours. This article does not review all the possible approaches that may be followed, but simply discusses some ideas and problems mainly taken from the current research of our laboratory.

AB - Theoretically, two predominant paths for obtaining more selective anticancer agents may be envisaged. These are: (a) to make compounds which distribute only or preferentially in cancer cells; (b) to make compounds that are able selectively to kill or to differentiate cancer cells. Although in the last two decades research into new anticancer drugs has not produced satisfactory results, there is solid ground on which novel strategies can be developed, mainly based on a much greater biological knowledge of human tumours. This article does not review all the possible approaches that may be followed, but simply discusses some ideas and problems mainly taken from the current research of our laboratory.

KW - antineoplastic drugs

KW - distribution

KW - DNA as a target of antitumour drugs

KW - human cancer cells

KW - immunoconjugates

KW - immunotoxins

UR - http://www.scopus.com/inward/record.url?scp=0024957913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024957913&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 535

EP - 555

JO - Cancer Surveys

JF - Cancer Surveys

SN - 0261-2429

IS - 3

ER -